AWA
NVCR icon

Aaron Wealth Advisors’s NovoCure NVCR Stock Holding History

Aaron Wealth Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$403K Buy
+25,280
New +$422K 0.02% 494
2026
Q1 		– Sell
-29,220
Closed -$378K – 742
2025
Q4 		$378K Sell
29,220
-9,005
-24% -$116K 0.02% 512
2025
Q3 		$494K Buy
+38,225
New +$511K 0.03% 412

Other funds holding NVCR

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Aaron Wealth Advisors's NVCR Position: Q3 2026 in Review

Aaron Wealth Advisors opened a new position in NovoCure (NVCR) in Q3 2026: 25,280 shares worth $403K. The stake represents 0.02% of the portfolio and ranks #494 among its holdings. This is a return to the name: Aaron Wealth Advisors previously reported a position in NVCR as recently as Q4 2025.

Aaron Wealth Advisors first reported a position in NVCR in Q3 2025 and has held it in 3 quarters since. The position peaked at $494K in Q3 2025. 15 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • Aaron Wealth Advisors held 25,280 shares of NovoCure worth $403K as of Q3 2026.
  • NovoCure was a new Aaron Wealth Advisors position in Q3 2026.
  • NovoCure made up 0.02% of Aaron Wealth Advisors's portfolio in Q3 2026, its #494 holding.
  • Aaron Wealth Advisors first reported a position in NovoCure in Q3 2025 and has held it in 3 quarters since.
  • Aaron Wealth Advisors's NovoCure position peaked at $494K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on Aaron Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.